Search results for "treatment strategy"

showing 10 items of 40 documents

57 TREATMENT OF BTP IN CANCER PATIENTS — A SYSTEMATIC UPDATE ON RELEVANT TREATMENT STRATEGIES

2009

Oncologymedicine.medical_specialtyAnesthesiology and Pain Medicinebusiness.industryInternal medicinemedicineCancerTreatment strategybusinessmedicine.diseaseEuropean Journal of Pain
researchProduct

Lung cancer: does age affect treatment strategy?

2009

Oncologymedicine.medical_specialtybusiness.industryInternal medicinemedicineTreatment strategyLung cancer elderlySettore MED/10 - Malattie Dell'Apparato RespiratoriobusinessAffect (psychology)Lung cancermedicine.disease
researchProduct

Treatment Strategies for Migraine Headache

2001

Pediatricsmedicine.medical_specialtyMigrainebusiness.industrymedicineTreatment strategyGeneral Medicinemedicine.diseasebusinessJAMA: The Journal of the American Medical Association
researchProduct

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies

2021

Background and aims: No consensus exists on how aggressively to treat relapsing–remitting multiple sclerosis (RRMS) nor on the timing of the treatment. The objective of this study was to evaluate disability trajectories in RRMS patients treated with an early intensive treatment (EIT) or with a moderate-efficacy treatment followed by escalation to higher-efficacy disease modifying therapy (ESC). Methods: RRMS patients with ⩾5-year follow-up and ⩾3 visits after disease modifying therapy (DMT) start were selected from the Italian MS Registry. EIT group included patients who received as first DMT fingolimod, natalizumab, mitoxantrone, alemtuzumab, ocrelizumab, cladribine. ESC group patients rec…

Pediatricsmedicine.medical_specialtybig data; disability trajectories; disease registry; multiple sclerosis.multiple sclerosis03 medical and health sciences0302 clinical medicineDisease registrybig dataMedicine030212 general & internal medicineRC346-429Original Researchbig data; disability trajectories; disease registry; multiple sclerosisPharmacologybusiness.industryMultiple sclerosisLong term disabilitymedicine.diseaseNeurologydisease registryTreatment strategySettore MED/26 - Neurologiadisability trajectoriesNeurology. Diseases of the nervous systemNeurology (clinical)business030217 neurology & neurosurgeryTherapeutic Advances in Neurological Disorders
researchProduct

Editorial: Environmental enrichment as a treatment? Epigenetic mechanisms, challenges and limitations

2021

PharmacologyEnvironmental enrichmentbusiness.industrytranslationalagingRM1-950Computational biologyDNAenvironmental enrichment (EE)aging; DNA; environmental enrichment (EE); epigenetic; translational; treatment strategiestreatment strategiesMedicineTreatment strategyPharmacology (medical)Therapeutics. PharmacologyEpigeneticsbusinessepigenetic
researchProduct

Physics of Shock-wave Lithotripsy

2018

Physicsmedicine.medical_treatmentAcousticsmedicineTreatment strategyShock wave lithotripsyExtracorporeal shock wave lithotripsy
researchProduct

How sustainable are new treatment strategies for NSCLC?

2019

Pulmonary and Respiratory MedicineOncologymedicine.medical_specialtyAcrylamidesAniline CompoundsLung Neoplasmsbusiness.industryCost-Benefit AnalysisMEDLINEAntineoplastic Agentsmedicine.diseaseAntibodies Monoclonal HumanizedText miningInternal medicineCarcinoma Non-Small-Cell LungMonoclonalmedicineCarcinomaTreatment strategyHumansbusinessThe Lancet. Respiratory medicine
researchProduct

The mutual relationship between heart failure and atrial fibrillation

2020

Atrial fibrillation (AF) and heart failure (HF) are evolving epidemies, together responsible for substantial human suffering and health-care expenditure. The simultaneous co-hexistence of the two conditions is associated with mortality rates higher than those observed in individuals with only one or none of them. Patients with concomitant HF and AF suffer from even worse symptoms and poorer prognosis, yet evidence-based evaluation and management of this group of patients is lacking. In this review, we evaluate the common mechanisms for the development of AF in HF patients and vice versa, focusing on the evidence for potential treatment strategies. Recent data have suggested that these patie…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyAdverse outcomesbusiness.industryMortality ratelcsh:Rheart failurelcsh:MedicineAtrial fibrillationArrhythmia-induced cardiomyopathymedicine.diseaseAtrial fibrillationHeart failure.Risk FactorsHeart failureConcomitantmedicineHumansTreatment strategyBest evidenceCardiology and Cardiovascular MedicineIntensive care medicinebusinessHealthcare system
researchProduct

Advances in asthma pathophysiology: stepping forward from the Maurizio Vignola experience

2015

Maurizio Vignola was a superb and innovative researcher, who wrote seminal papers on the biology of airway epithelium in asthma. Inflammation and remodelling were the main topics of his research, mostly conducted in biopsy specimens from patients with asthma of variable severity, encompassing the entire spectrum of the disease from mild to severe asthma. His observations contributed to define the biology of asthma as we know it today, and opened the way to the personalised treatment of asthma. His group has successfully continued to investigate the biology and clinical aspects of bronchial asthma, with major interest in the clinical use of biomarkers to monitor disease activity, and in the …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVariable severityAsthma phenotypesSevere asthmaDrug ResistanceMEDLINEDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAdrenal Cortex HormoneDisease activityGlucocorticoidAdrenal Cortex Hormonesimmune system diseasesmedicineHumansIntensive care medicineGlucocorticoidsAsthmalcsh:RC705-779Inflammationbusiness.industrylcsh:Diseases of the respiratory systemBiomarkermedicine.diseaseAsthmarespiratory tract diseasesPhysical therapyAirway RemodelingTreatment strategybusinessBiomarkersHumanEuropean Respiratory Review
researchProduct

Type II Odontoid Fracture: a case series highlighting the treatment strategies

2019

Background: A type II odontoid fracture, if unstable, can cause spinal cord damage. In this case, it is essential to choose the correct treatment—but the issues of what the correct treatment is and which of the different surgical options is best are quite controversial. In this paper we present strategies for treatment of type II odontoid fracture. Materials and Methods: Thirty consecutive cases of type II odontoid fracture were treated at the Division of Neurosurgery at Villa Sofia Hospital in Palermo (23 cases) and at the Neurosurgical Clinic, University Hospital of Palermo (seven cases), from January 2011 to August 2016. Four patients were treated with external immobilization. Twenty-six…

Type II odontoid fracturemedicine.medical_specialtyC1–C2 instabilitySettore MED/27 - Neurochirurgiabusiness.industryBone ScrewExternal FixatorSpinal cord030218 nuclear medicine & medical imagingSurgeryFracture Fixation InternalOdontoid Proce03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureC1–C2 articular screwFracture FixationmedicineSpinal FracturesTreatment strategybusinessOdontoid screw030217 neurology & neurosurgeryHumanOdontoid fracture
researchProduct